Janus Henderson Group PLC Purchases 12,448 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Janus Henderson Group PLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,100,715 shares of the company’s stock after purchasing an additional 12,448 shares during the period. Janus Henderson Group PLC owned 1.28% of HealthEquity worth $89,851,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Pacer Advisors Inc. grew its stake in HealthEquity by 78.3% in the 4th quarter. Pacer Advisors Inc. now owns 12,861 shares of the company’s stock valued at $853,000 after purchasing an additional 5,646 shares during the period. McGlone Suttner Wealth Management Inc. bought a new position in HealthEquity during the fourth quarter valued at about $29,000. DAVENPORT & Co LLC increased its holdings in HealthEquity by 31.3% during the fourth quarter. DAVENPORT & Co LLC now owns 507,135 shares of the company’s stock worth $33,636,000 after buying an additional 120,987 shares during the last quarter. Cambiar Investors LLC raised its position in HealthEquity by 1.2% in the fourth quarter. Cambiar Investors LLC now owns 200,060 shares of the company’s stock worth $13,264,000 after acquiring an additional 2,391 shares during the period. Finally, Mutual of America Capital Management LLC boosted its stake in HealthEquity by 4.0% in the fourth quarter. Mutual of America Capital Management LLC now owns 102,200 shares of the company’s stock valued at $6,776,000 after acquiring an additional 3,905 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Price Performance

NASDAQ:HQY traded up $0.62 during midday trading on Wednesday, hitting $79.04. The company had a trading volume of 42,950 shares, compared to its average volume of 616,417. The stock’s fifty day moving average price is $81.44 and its 200-day moving average price is $80.14. HealthEquity, Inc. has a 52-week low of $61.81 and a 52-week high of $88.26. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $6.88 billion, a PE ratio of 85.24, a P/E/G ratio of 1.34 and a beta of 0.57.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.08. The firm had revenue of $287.60 million during the quarter, compared to analysts’ expectations of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. As a group, research analysts expect that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Insider Transactions at HealthEquity

In related news, Vice Chairman Stephen Neeleman sold 400 shares of HealthEquity stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total value of $34,000.00. Following the transaction, the insider now owns 90,515 shares in the company, valued at approximately $7,693,775. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Vice Chairman Stephen Neeleman sold 400 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total value of $34,000.00. Following the transaction, the insider now owns 90,515 shares in the company, valued at $7,693,775. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The disclosure for this sale can be found here. In the last ninety days, insiders sold 77,511 shares of company stock worth $6,314,446. 2.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

HQY has been the subject of several research analyst reports. Robert W. Baird raised their price target on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. KeyCorp raised their target price on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Raymond James upped their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. Bank of America reissued a “buy” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, July 3rd. Finally, JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a report on Tuesday, April 2nd. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $101.67.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.